Details of the Drug
General Information of Drug (ID: DMRFBD0)
Drug Name |
Deprenyl
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2323-36-6; CHEBI:50217; N,alpha-Dimethyl-N-2-propynylphenethylamine; N,alpha-Dimethyl-N-2-propynylbenzeneethanamine; methyl(1-phenylpropan-2-yl)(prop-2-yn-1-yl)amine; PHENETHYLAMINE, N,alpha-DIMETHYL-N-2-PROPYNYL-; N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine; dl-Deprenyl; phenylisopropyl-n-methylpropinylamine; AC1L1JT6; CHEMBL8663; SCHEMBL74753; cid_92913; 4-fluorodeprenyl, (-)-isomer; BDBM39862; MEZLKOACVSPNER-UHFFFAOYSA-N; HMS2089B08; AC1Q2862; MCULE-3188554308; ACM2323366
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure | ||||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 187.28 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 2.8 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 1 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References